Dr. Atanackovic is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
655 W. Baltimore Street
Baltimore, MD 21201Phone+1 410-706-1946Fax+1 410-328-6559
Education & Training
- Freie University Berlin Faculty of MedicineClass of 1998
Certifications & Licensure
- MD State Medical License 2020 - 2026
- UT State Medical License 2013 - 2026
Publications & Presentations
PubMed
- Carvykti CAR T-cell morphology in cellavision peripheral smear reviews.Michael E Kallen, Rima Koka, Djordje Atanackovic
Journal of Hematopathology. 2024-12-01 - Coordinated antiviral immune response in a patient with myeloma and systemic adenovirus infection post-BCMA CAR T cells.Mehmet H Kocoglu, Tim Luetkens, Jacqueline T Bork, John Baddley, Destiny Omili
Blood Advances. 2024-11-26 - Extracellular vesicles containing SARS-CoV-2 proteins are associated with multi-organ dysfunction and worse outcomes in patients with severe COVID-19.Diego de Miguel-Perez, Marisol Arroyo-Hernandez, Sabrina La Salvia, Muthukumar Gunasekaran, Edward M Pickering
Journal of Extracellular Vesicles. 2024-11-01
Abstracts/Posters
- B Cell Maturation Antigen-Specific CAR T Cells for Relapsed or Refractory Multiple Myeloma: A Meta-AnalysisDjordje Atanackovic, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- B Cell Maturation Antigen-Specific CAR T Cells for Relapsed or Refractory Multiple Myeloma: A Meta-AnalysisDjordje Atanackovic, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Press Mentions
- University of Maryland Greenebaum Comprehensive Cancer Center Offers Novel Next-Generation CAR T-cell Therapy for B-cell Lymphomas in First-in-Human Clinical TrialNovember 25th, 2024
- New Cancer Treatment Changing Outlook for Those with Blood CancersJuly 11th, 2022
- COVID Vaccine Protection May Be Weaker in Some Cancer Patients. But Experts Say They Should Still Get VaccinatedMay 17th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: